Sangamo Therapeutics Inc (SGMO)
0.503
+0.01
(+2.03%)
USD |
NASDAQ |
Apr 25, 16:00
0.5029
0.00 (0.00%)
After-Hours: 20:00
Sangamo Therapeutics Price to Book Value: 1.086 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 1.086 |
| April 24, 2024 | 1.064 |
| April 23, 2024 | 1.124 |
| April 22, 2024 | 1.101 |
| April 19, 2024 | 1.104 |
| April 18, 2024 | 1.047 |
| April 17, 2024 | 1.114 |
| April 16, 2024 | 1.170 |
| April 15, 2024 | 1.198 |
| April 12, 2024 | 1.173 |
| April 11, 2024 | 1.177 |
| April 10, 2024 | 1.131 |
| April 09, 2024 | 1.214 |
| April 08, 2024 | 1.220 |
| April 05, 2024 | 1.211 |
| April 04, 2024 | 1.240 |
| April 03, 2024 | 1.317 |
| April 02, 2024 | 1.255 |
| April 01, 2024 | 1.312 |
| March 28, 2024 | 1.447 |
| March 27, 2024 | 1.348 |
| March 26, 2024 | 1.302 |
| March 25, 2024 | 1.385 |
| March 22, 2024 | 1.517 |
| March 21, 2024 | 2.094 |
| Date | Value |
|---|---|
| March 20, 2024 | 1.762 |
| March 19, 2024 | 1.662 |
| March 18, 2024 | 1.837 |
| March 15, 2024 | 1.684 |
| March 14, 2024 | 1.684 |
| March 13, 2024 | 1.695 |
| March 12, 2024 | 1.859 |
| March 11, 2024 | 1.905 |
| March 08, 2024 | 1.956 |
| March 07, 2024 | 1.976 |
| March 06, 2024 | 2.171 |
| March 05, 2024 | 2.214 |
| March 04, 2024 | 2.192 |
| March 01, 2024 | 2.386 |
| February 29, 2024 | 2.493 |
| February 28, 2024 | 2.300 |
| February 27, 2024 | 2.428 |
| February 26, 2024 | 2.407 |
| February 23, 2024 | 2.428 |
| February 22, 2024 | 2.364 |
| February 21, 2024 | 2.654 |
| February 20, 2024 | 2.536 |
| February 16, 2024 | 2.966 |
| February 15, 2024 | 2.257 |
| February 14, 2024 | 1.62 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3905
Minimum
Nov 10 2023
4.932
Maximum
Dec 23 2020
2.370
Average
2.464
Median
Sep 27 2022
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 2.125 |
| Perspective Therapeutics Inc | 12.49 |
| Protalix BioTherapeutics Inc | 2.568 |
| Electromed Inc | 3.451 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 0.4983 |
| PEG Ratio | -0.0194 |
| Price | 0.503 |
| Earnings Yield | -292.2% |
| Market Cap | 89.99M |
| PEGY Ratio | -0.0194 |